Vanguard Group’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-13,500
| Closed | -$151K | – | 4657 |
|
|
2022
Q4 | $151K | Sell |
13,500
-413,595
| -97% | -$4.62M | ﹤0.01% | 4346 |
|
|
2022
Q3 | $2.4M | Sell |
427,095
-239,620
| -36% | -$1.35M | ﹤0.01% | 3678 |
|
|
2022
Q2 | $2.89M | Sell |
666,715
-948
| -0.1% | -$4.11K | ﹤0.01% | 3645 |
|
|
2022
Q1 | $7.77M | Buy |
667,663
+5,490
| +0.8% | +$63.9K | ﹤0.01% | 3281 |
|
|
2021
Q4 | $12.1M | Buy |
662,173
+35,906
| +6% | +$656K | ﹤0.01% | 3117 |
|
|
2021
Q3 | $7.42M | Buy |
626,267
+4,471
| +0.7% | +$53K | ﹤0.01% | 3415 |
|
|
2021
Q2 | $10.7M | Buy |
621,796
+60,886
| +11% | +$1.05M | ﹤0.01% | 3168 |
|
|
2021
Q1 | $10.3M | Buy |
560,910
+32,705
| +6% | +$598K | ﹤0.01% | 3134 |
|
|
2020
Q4 | $9.94M | Buy |
528,205
+37,187
| +8% | +$700K | ﹤0.01% | 3000 |
|
|
2020
Q3 | $10.4M | Buy |
491,018
+1,236
| +0.3% | +$26.1K | ﹤0.01% | 2766 |
|
|
2020
Q2 | $14.1M | Buy |
489,782
+351,931
| +255% | +$10.2M | ﹤0.01% | 2592 |
|
|
2020
Q1 | $4.83M | Sell |
137,851
-13,555
| -9% | -$474K | ﹤0.01% | 2986 |
|
|
2019
Q4 | $3.7M | Buy |
+151,406
| New | +$3.7M | ﹤0.01% | 3271 |
|